Paul Hastings Advised Piper Sandler, Oppenheimer & Co. on Skye Biosciences' $50.25M PIPE Financing
January 31, 2024
January 31, 2024
LOS ANGELES, California, Jan. 31 -- Paul Hastings, a law firm, issued the following news:
Paul Hastings LLP advised Piper Sandler as lead placement agent and Oppenheimer & Co. as placement agent in connection with Skye Bioscience's $50.25 million private placement (PIPE).
The PIPE financing consists of the sale of (i) 11,822,124 shares of Skye's common stock at $2.305 per share and (ii) to certain investors, in lieu of common stock, pre-funded warrants to . . .
Paul Hastings LLP advised Piper Sandler as lead placement agent and Oppenheimer & Co. as placement agent in connection with Skye Bioscience's $50.25 million private placement (PIPE).
The PIPE financing consists of the sale of (i) 11,822,124 shares of Skye's common stock at $2.305 per share and (ii) to certain investors, in lieu of common stock, pre-funded warrants to . . .